Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection
about
Galectin-9 functionally impairs natural killer cells in humans and miceA cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllersGalectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.Human cytomegalovirus upregulates expression of the lectin galectin 9 via induction of beta interferonCompartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL.TIM-3 does not act as a receptor for galectin-9.Galectin-9 activates and expands human T-helper 1 cells.Select host restriction factors are associated with HIV persistence during antiretroviral therapy.Methamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targetsBroad-spectrum antivirals against viral fusion.Human Galectin-9 Is a Potent Mediator of HIV Transcription and ReactivationSubset- and Antigen-Specific Effects of Treg on CD8+ T Cell Responses in Chronic HIV InfectionNegative CD4 + TIM-3 signaling confers resistance against cold preservation damage in mouse liver transplantation.Serum Galectin-9 and Galectin-3-Binding Protein in Acute Dengue Virus Infection.Susceptibility to CD8 T-cell-mediated killing influences the reservoir of latently HIV-1-infected CD4 T cellsHigh Expression of Antiviral and Vitamin D Pathway Genes Are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals.Tim-3 inhibits macrophage control of Listeria monocytogenes by inhibiting Nrf2.Unravelling the mechanisms of durable control of HIV-1.The bitter side of sweet: the role of Galectin-9 in immunopathogenesis of viral infections.Galectin-9: From cell biology to complex disease dynamics.Galectin-9 binds to O-glycans on protein disulfide isomerase.Molecular characterization of T-cell immunoglobulin mucin domain-3 and Galectin-9 genes of swamp- and riverine-type water buffaloes.Tim-3 suppression combined with TLR3 activation enhances antiviral immune response in patients with chronic HCV infection.HIV-1 Infection Dysregulates Cell Cycle Regulatory Protein p21 in CD4+ T Cells Through miR-20a and miR-106b Regulation.Translational Implication of Galectin-9 in the Pathogenesis and Treatment of Viral Infection.Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection.Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer.T-cell immunoglobulin- and mucin-domain-containing molecule 3 genetic variants and HIV+ non-Hodgkin lymphomas.Functional expression of Tim-3 on blasts and clinical impact of its ligand galectin-9 in myelodysplastic syndromes.GalNAc-Specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors.α4β7+ CD4+ effector/effector memory T cells differentiate into productively and latently infected central memory T cells by TGFβ1 during HIV-1 infection.Tim3+ Foxp3 + Treg Cells Are Potent Inhibitors of Effector T Cells and Are Suppressed in Rheumatoid Arthritis.Adaptive NKG2C+CD57+ Natural Killer Cell and Tim-3 Expression During Viral Infections.TIM-3, a Possible Target for Immunotherapy in Cancer and Chronic Viral Infections
P2860
Q24317152-37A9B249-EDC6-4D32-8DC3-C22662BC090DQ33811660-2B71067A-FFDA-46B1-8533-37294D6FB5FAQ33828349-867BA637-86F7-4992-91E1-0935FC192CABQ34262198-D38F98AA-AB18-470F-8E56-119CD18E5E8AQ34550802-420EF23A-B578-4A57-9FB7-F16B0418023BQ34649690-98D5069D-EFDF-48BD-AE94-FEFA44353623Q34761415-6D1B07F1-3685-4DF4-AEBE-A4ACDD9B4B65Q35271996-FFAC725B-3497-430A-BFE5-7464FCEA3B09Q35997428-C847C3D7-A33A-451F-974A-AAD6C33C7D8CQ36010083-D28A1089-D171-4CB6-96D0-9108C693AABCQ36037844-26E4CC91-F966-40C0-A337-508F8D25461DQ36187428-0799EC92-D67E-4623-BE0D-299A37804F70Q36509345-69DB292D-E958-4F0B-849A-ECC7A772331AQ37050534-4034AA34-7086-4451-BB8C-C9CF2FA831A6Q37417614-19DCFC3C-4954-4A12-AA7C-7A68BDE68DDCQ37637890-6A75128F-BFC6-4257-A703-BBA153CE8978Q37644227-67BD9C75-7EB2-49B4-95C3-1822EAD79E8CQ38116710-03A678EE-3ADA-4898-8B90-00E04B47D7F6Q38373689-F684755E-0240-4C5C-BE82-C78BEAA38177Q38942909-CC712C76-AC51-4EF4-8D92-DB13E9B095ECQ40082362-B3246C1E-B22D-4B47-9378-F1F76121925BQ40461629-C6C48ACA-6C58-42B3-8C0B-C41C1FFC0DC6Q40688859-7A3195FE-8CB4-4D3F-B4BC-79D035CD7016Q40836975-05CAE6CC-523C-4FC2-B4E0-987BE33EC569Q41921662-D80ADF7D-10D2-4F6C-94ED-D3EB45EE3C6FQ42282987-992E74D6-B81B-4AD0-A00D-42230FD3DD58Q42369857-E7F838F0-2A84-42F3-BB1B-D1DACE84366EQ43531060-25E1D368-972D-42C2-AAA5-35CEEC201033Q47117864-9EA5D14E-37ED-4703-AA20-DCFF3DD28D6BQ47269144-5A4E8DCD-A1A0-4FB3-8786-2507E9E03F0EQ49545801-F7C65F21-1D5C-45AF-901A-2422ABD1E457Q54394169-2E47FECE-EA47-4E11-A502-11F304E8C332Q55009853-3BA0D930-C773-4091-AAFD-CA8BAF38200FQ56897131-48DD7A30-E265-42EC-9F7C-6912DC78696D
P2860
Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Galectin-9 binding to Tim-3 re ...... susceptible to HIV-1 infection
@ast
Galectin-9 binding to Tim-3 re ...... susceptible to HIV-1 infection
@en
type
label
Galectin-9 binding to Tim-3 re ...... susceptible to HIV-1 infection
@ast
Galectin-9 binding to Tim-3 re ...... susceptible to HIV-1 infection
@en
prefLabel
Galectin-9 binding to Tim-3 re ...... susceptible to HIV-1 infection
@ast
Galectin-9 binding to Tim-3 re ...... susceptible to HIV-1 infection
@en
P2093
P2860
P1433
P1476
Galectin-9 binding to Tim-3 re ...... susceptible to HIV-1 infection
@en
P2093
Helen Horton
Mitsuomi Hirashima
Shokrollah Elahi
Toshiro Niki
P2860
P304
P356
10.1182/BLOOD-2011-11-389585
P407
P577
2012-03-21T00:00:00Z